Humacyte, Inc. (NASDAQ:HUMA) Q3 2022 Earnings Conference Call November 10, 2022 8:00 AM ET

Company Participants

Lauren Marek - LifeSci Advisors, IR

Laura Niklason - President & CEO

Dale Sander - CFO & Chief Corporate Development Officer

Conference Call Participants

Eric Anderson - Cowen

Suraj Kalia - Oppenheimer

Bruce Jackson - The Benchmark Company

Ryan Zimmerman - BTIG

Operator

Good morning, ladies and gentlemen, and welcome to the Humacyte Third Quarter 2022 Results Conference Call. Currently, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. As a reminder, this conference call is being recorded.

I will now turn the call over to Lauren Marek with LifeSci Advisors. Please go ahead.

Lauren Marek

Thank you, Operator. Before we proceed with the call, I would like to remind everyone that certain statements made during this call are forward-looking statements under U.S. federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. Additional information concerning factors that could cause actual results to differ from statements made on this call is contained in our periodic reports filed with the SEC.

The forward-looking statements made during this call speak only as of the date hereof and the company undertakes no obligation to update or revise the forward-looking statements except as required by law. Information presented on this call is contained in the press release we issued this morning and in our Form 10-Q, which will be filed today and maybe accessed from the Investors page of the Humacyte website.

Joining me on today’s call from Humacyte are Dr. Laura Niklason, President and Chief Executive Officer; Dale Sander, Chief Financial Officer and Chief Corporate Development Officer; and Dr. Heather Prichard, Chief Operating Officer. Dr. Niklason will provide a summary of the company’s progress during the quarter and recent weeks, and Dale will review the company’s financial results. Following their prepared remarks, the management team will be available for your questions.

I will now turn the call over to Dr. Niklason.

Laura Niklason

Thank you, Lauren. Good morning, everyone, and thank you for joining us on our third quarter 2022 financial results and business update call. During this call, I'll review our recent highlights and our progress in our key program before turning the call over to Dale for a review of our financial results. Then, we'll be happy to open the call up to your questions.